Fuji Film 手ぶら

Call for Abstracts

Abstract Submission Period

From Thursday, July 19 to Tuesday, September 11, 2018 September 25, 2018 Final deadline has been extended to Noon, October 2, 2018 Abstract submission is now closed.

Presentation Style

  • Oral presentation
  • Poster presentation (Time for oral presentation available)

* The detailed information for preparation of the presentation slides and data will be announced after the notification of the acceptance or rejection.

Presentation Categories

Please select the most appropriate category for your presentation.
The Program Committee will make the final decision on the presentation categories.

Symposium / Panel discussion / Workshop / Video Workshop categories

Purpose of application for each session Please refer to the program page for details.


  • EGJ tumor update: Topics from epidemiology and diagnosis
  • EGJ tumor update: Topics from current treatment
  • New evidence for perioperative chemotherapy
  • The role of conversion surgery
  • New insights in molecular profiling

Panel discussion

  • Pitfalls of stomach cancer diagnosis
  • The role of splenic hilar lymph node dissection in proximal gastric cancer
  • Treatment for gastric cancer in the elderly
  • Virtual cancer board
    1) Early gastric cancer
    2) Advanced gastric cancer

Video Workshop

  • Robotic surgery for gastric cancer
  • Troubleshooting in laparoscopic gastrectomy
  • Current status and perspectives of para-aortic lymph node dissection


  • Navigation surgery for gastric cancer
  • Establishment of QOL assessment after gastrectomy
  • Current status and outlook of palliative treatment (stent, chemotherapy, surgery, etc.)
  • Evaluation of nutritional index and significance of intervention
  • Chemotherapy with limited indication
  • Treatment strategy for HER2-positive gastric cancer
  • Treatment for peritoneal metastasis
  • Treatment strategy for remnant gastric cancer
  • The role of multidisciplinary team medical treatment for gastric cancer
  • Application of artificial intelligence in diagnosis of gastric cancer
  • Clinicopathological findings and molecular profile of gastric cancer with a gastric mucin phenotype


Please select the most appropriate category for your presentation from below and submit your abstract:

The Program Committee will make the final decision on the presentation categories.

01 Epidemiology 42 Postoperative complications
02 Pathology 43 ERAS
03 Molecular biology 44 Sentinel lymph node
04 Molecular pathology 45 Peritoneal dissemination
05 Genomics 46 CART
06 Epigenomics 47 Stent placement
07 Development of gastric cancer 48 Liver metastasis
08 Translational research 49 Recurrence
09 H.pylori 50 Early gastric cancer
10 Progression of gastric cancer 51 Advanced gastric cancer
11 Micrometastasis 52 Scirrhous gastric cancer
12 Intraoperative frozen section 53 Gastric stump carcinoma
13 Cancer stem cell 54 Multiple gastric cancers
14 Gastric cancer screening 55 Gastric tube cancer
15 Endoscopic diagnosis 56 Gastric cardia cancer
16 IEE 57 Esophago-gastric junction cancer
17 Endoscopic resection 58 Gastric cancer in elderly patients
18 Imaging diagnosis 59 AFP-producing gastric cancer
19 Artificial Intelligence 60 EBV-related gastric cancer
20 Clinical study 61 Gastrointestinal stromal tumor
21 Chemotherapy 62 Malignant lymphoma
22 Neoadjuvant chemotherapy 63 Gastric neuroendocrine tumor
23 Adjuvant chemotherapy 64 Fundic gland type gastric cancer
24 Second-line chemotherapy 65 Guidelines
25 Intraperitoneal chemotherapy 66 Clinical pathway
26 Molecular targeted therapy 67 Postoperative surveillance
27 Biomarker 68 Long-term survival case after chemotherapy
28 Immunotherapy 69 Outcome
29 Radiation therapy 70 Prognostic factor
30 Chemoradiotherapy 71 QOL assessment
31 Conversion surgery 72 Nutrition
32 Surgery 73 Obesity
33 Laparoscopic surgery 74 Japanese Classification of Gastric Carcinoma
34 Robotic surgery 75 Multidisciplinary treatment
35 Function-preserving surgery 76 Palliative therapy
36 Cytoreductive surgery 77 Team approach
37 LECS 78 MDT conference
38 Surgical navigation 79 Medical cooperation
39 Postoperative functional assessment 80 Oral care
40 Postgastrectomy syndrome 81 Others
41 Perioperative management

Abstract Acceptance or Rejection

Please understand that the decision on abstract acceptance/rejection and presentation style (oral or poster) is left to the sole discretion of the Congress President.

Abstract Submission

Language for abstract


Language for presentation


Language for presentation slides


The number of characters (including spaces)

Title up to 100 characters
Abstract: up to 1600 characters

Travel Grants

We invite you to submit applications for travel grants with details as below. Please apply by selecting "Apply" at the time of abstract submission.

  • Applicant's eligibility
    • The applicant must be aged 40 or under at the time of abstract submission.
    • The applicant must be working or training in a country other than Japan.
    • The applicant may submit only one abstract.
  • The presentation must be given and slides must be prepared in English.
  • The travel grant of USD 500.00 and accommodation up to 2 nights will be awarded and participation will be free of charge. The applicant must arrange, however, transportation etc. on his/her own.
  • The Congress President reserves the right of acceptance or rejection for all submitted presentations.
  • It is the applicant's own responsibility to obtain the proper visa to enter Japan.
  • Applicants will individually be notified of travel grant decisions by December 2018.

Conflict of Interest Disclosure

The author is required to report applicable COI (Conflict of Interest) by completing the "Conflict of Interest Disclosure" part in the Abstract Submission process.

Abstract Submission

Abstract Submission is now closed.
Thank you for your submission.


Congress Secretariat
c/o Congress Corporation
Kohsai Kaikan Bldg.
5-1, Kojimachi, Chiyoda-ku, Tokyo, 102-8481, Japan
Tel: +81-3-5216-5318 Fax: +81-3-5216-5552